News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
FDA Finds Grime at Johnson & Johnson Plant, Urges Use of Generics
May 5, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- U.S. inspectors found thick dust and contaminated ingredients at the Johnson & Johnson (JNJ.N) plant that produces Children's Tylenol and dozens of other products that were recalled last week.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Johnson & Johnson Family of Companies
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Drug pricing
Trump Administration Reaches Pricing Agreements with 9 More Drugmakers
December 22, 2025
·
2 min read
·
Nick Paul Taylor
Policy
Disc Shares Slip Amid Report FDA’s Prasad is Skeptical of Bitopertin’s Efficacy
December 22, 2025
·
2 min read
·
Nick Paul Taylor
Deals
Inside the 2026 Biotech Landscape: Innovation, Investment and Global Momentum
December 18, 2025
·
1 min read
·
BioSpace Insights
Regulatory
FDA Mulls National Priority Vouchers for Two Potential Merck Blockbusters: Report
December 18, 2025
·
2 min read
·
Tristan Manalac